癌症患者的口腔健康状况和预防措施。

Q4 Medicine Georgian medical news Pub Date : 2024-09-01
T Dundua, V Margvelashvili, M Kalandadze, S Dalalishvili
{"title":"癌症患者的口腔健康状况和预防措施。","authors":"T Dundua, V Margvelashvili, M Kalandadze, S Dalalishvili","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Oncology patients frequently face a variety of oral side effects as a result of cancer treatments like chemotherapy, radiation therapy, and targeted therapy. One common issue is periodontitis. Additionally, patients with COVID-19 have reported a range of oral symptoms, including necrotizing periodontal disease. The objective of our study is to evaluate the oral health status of cancer patients during COVID-19 infection.</p><p><strong>Material and methods: </strong>The research involved 213 Georgian citizens' aged 18 to 65, divided into four groups: Group I consisted of 120 healthy individuals (without cancer); Group II included 60 healthy individuals who had contracted COVID-19; Group III comprised 40 cancer patients; and Group IV included 85 cancer patients who also had COVID-19. We aimed to analyze the correlation between oral health characteristics and both COVID-19 status and cancer diagnosis, as well as the types of cancer treatments received.</p><p><strong>Results: </strong>The study showed an increased signs in oral index scores in cancer and covid groups compared to healthy group. Bleeding index: in group I - 0.20+0.41, in group II - 0.85+1.13, in group III - 0.48+0.85 and in group IV 0.95+1.20 p=0.079). Loss of gingival attachment: 0-3 mm: in group I - 2 (10%), in group II - 33 (55%), in group III - 7 (14.58%), in group IV - 1 (12.94%) (p<0.0001); 4-5 mm: in group I- 0, in group II - 20 (33.3%), in group III - 13 (27.08%), in group IV - 25 (29.41%) (p=0.2489; 6-8 mm: in group I - 0, in group II - 6 (7.06%), in group III - 1 (2.08%) ), in IV group - 6 (7.06%) (p=0.2200). We diagnosed the 40 patients with periodontitis. Cancer and Cancer+Covid group show a significant positive correlation with periodontitis, (r=0.197, p=0.004; and r=0.144, p=0.036 respectively).</p><p><strong>Conclusions: </strong>• Cancer patients exhibit a high incidence of periodontitis, which is exacerbated by COVID-19 transmission. However, receiving a booster vaccine dose can significantly reduce the risk of tooth loss. • The oral health status of cancer patients must be prioritized, necessitating the development of an appropriate protocol during and after cancer treatment. Special attention should be given to those patients who have also contracted COVID-19. • To prevent periodontitis and tooth loss during cancer treatment, it is crucial for patients, particularly those infected with COVID-19, to maintain regular dental follow-ups.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 354","pages":"213-217"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"THE ORAL HEALTH STATUS AND PREVENTIVE MEASUREMENTS FOR CANCER PATIENTS.\",\"authors\":\"T Dundua, V Margvelashvili, M Kalandadze, S Dalalishvili\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Oncology patients frequently face a variety of oral side effects as a result of cancer treatments like chemotherapy, radiation therapy, and targeted therapy. One common issue is periodontitis. Additionally, patients with COVID-19 have reported a range of oral symptoms, including necrotizing periodontal disease. The objective of our study is to evaluate the oral health status of cancer patients during COVID-19 infection.</p><p><strong>Material and methods: </strong>The research involved 213 Georgian citizens' aged 18 to 65, divided into four groups: Group I consisted of 120 healthy individuals (without cancer); Group II included 60 healthy individuals who had contracted COVID-19; Group III comprised 40 cancer patients; and Group IV included 85 cancer patients who also had COVID-19. We aimed to analyze the correlation between oral health characteristics and both COVID-19 status and cancer diagnosis, as well as the types of cancer treatments received.</p><p><strong>Results: </strong>The study showed an increased signs in oral index scores in cancer and covid groups compared to healthy group. Bleeding index: in group I - 0.20+0.41, in group II - 0.85+1.13, in group III - 0.48+0.85 and in group IV 0.95+1.20 p=0.079). Loss of gingival attachment: 0-3 mm: in group I - 2 (10%), in group II - 33 (55%), in group III - 7 (14.58%), in group IV - 1 (12.94%) (p<0.0001); 4-5 mm: in group I- 0, in group II - 20 (33.3%), in group III - 13 (27.08%), in group IV - 25 (29.41%) (p=0.2489; 6-8 mm: in group I - 0, in group II - 6 (7.06%), in group III - 1 (2.08%) ), in IV group - 6 (7.06%) (p=0.2200). We diagnosed the 40 patients with periodontitis. Cancer and Cancer+Covid group show a significant positive correlation with periodontitis, (r=0.197, p=0.004; and r=0.144, p=0.036 respectively).</p><p><strong>Conclusions: </strong>• Cancer patients exhibit a high incidence of periodontitis, which is exacerbated by COVID-19 transmission. However, receiving a booster vaccine dose can significantly reduce the risk of tooth loss. • The oral health status of cancer patients must be prioritized, necessitating the development of an appropriate protocol during and after cancer treatment. Special attention should be given to those patients who have also contracted COVID-19. • To prevent periodontitis and tooth loss during cancer treatment, it is crucial for patients, particularly those infected with COVID-19, to maintain regular dental follow-ups.</p>\",\"PeriodicalId\":12610,\"journal\":{\"name\":\"Georgian medical news\",\"volume\":\" 354\",\"pages\":\"213-217\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Georgian medical news\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Georgian medical news","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

肿瘤患者在接受化疗、放疗和靶向治疗等癌症治疗后,经常会面临各种口腔副作用。其中一个常见问题就是牙周炎。此外,COVID-19 患者也报告了一系列口腔症状,包括坏死性牙周病。我们的研究旨在评估 COVID-19 感染期间癌症患者的口腔健康状况:研究涉及 213 名 18 至 65 岁的格鲁吉亚公民,分为四组:第一组包括 120 名健康人(未患癌症);第二组包括 60 名感染 COVID-19 的健康人;第三组包括 40 名癌症患者;第四组包括 85 名同样感染 COVID-19 的癌症患者。我们的目的是分析口腔健康特征与 COVID-19 状态、癌症诊断以及所接受的癌症治疗类型之间的相关性:结果:研究显示,与健康组相比,癌症组和 COVID-19 组的口腔指数得分有增加的迹象。出血指数:I 组为 0.20+0.41,II 组为 0.85+1.13,III 组为 0.48+0.85,IV 组为 0.95+1.20(P=0.079)。牙龈附着丧失:0-3毫米:I组-2(10%),II组-33(55%),III组-7(14.58%),IV组-1(12.94%)(P结论:- 癌症患者牙周炎的发病率很高,COVID-19 的传播会加剧牙周炎。然而,接种一剂加强型疫苗可大大降低牙齿脱落的风险。- 必须优先考虑癌症患者的口腔健康状况,因此有必要在癌症治疗期间和治疗后制定适当的方案。应特别关注那些同时感染了 COVID-19 的患者。- 为防止癌症治疗期间出现牙周炎和牙齿脱落,患者,尤其是感染 COVID-19 的患者,必须定期进行牙科随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
THE ORAL HEALTH STATUS AND PREVENTIVE MEASUREMENTS FOR CANCER PATIENTS.

Oncology patients frequently face a variety of oral side effects as a result of cancer treatments like chemotherapy, radiation therapy, and targeted therapy. One common issue is periodontitis. Additionally, patients with COVID-19 have reported a range of oral symptoms, including necrotizing periodontal disease. The objective of our study is to evaluate the oral health status of cancer patients during COVID-19 infection.

Material and methods: The research involved 213 Georgian citizens' aged 18 to 65, divided into four groups: Group I consisted of 120 healthy individuals (without cancer); Group II included 60 healthy individuals who had contracted COVID-19; Group III comprised 40 cancer patients; and Group IV included 85 cancer patients who also had COVID-19. We aimed to analyze the correlation between oral health characteristics and both COVID-19 status and cancer diagnosis, as well as the types of cancer treatments received.

Results: The study showed an increased signs in oral index scores in cancer and covid groups compared to healthy group. Bleeding index: in group I - 0.20+0.41, in group II - 0.85+1.13, in group III - 0.48+0.85 and in group IV 0.95+1.20 p=0.079). Loss of gingival attachment: 0-3 mm: in group I - 2 (10%), in group II - 33 (55%), in group III - 7 (14.58%), in group IV - 1 (12.94%) (p<0.0001); 4-5 mm: in group I- 0, in group II - 20 (33.3%), in group III - 13 (27.08%), in group IV - 25 (29.41%) (p=0.2489; 6-8 mm: in group I - 0, in group II - 6 (7.06%), in group III - 1 (2.08%) ), in IV group - 6 (7.06%) (p=0.2200). We diagnosed the 40 patients with periodontitis. Cancer and Cancer+Covid group show a significant positive correlation with periodontitis, (r=0.197, p=0.004; and r=0.144, p=0.036 respectively).

Conclusions: • Cancer patients exhibit a high incidence of periodontitis, which is exacerbated by COVID-19 transmission. However, receiving a booster vaccine dose can significantly reduce the risk of tooth loss. • The oral health status of cancer patients must be prioritized, necessitating the development of an appropriate protocol during and after cancer treatment. Special attention should be given to those patients who have also contracted COVID-19. • To prevent periodontitis and tooth loss during cancer treatment, it is crucial for patients, particularly those infected with COVID-19, to maintain regular dental follow-ups.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Georgian medical news
Georgian medical news Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
207
期刊最新文献
ALOPECIA AREATA PROFILING SHOWS LNCRNAS REGULATE THE SUPPRESSED EXPRESSION OF KERATIN. ANALYSIS OF BLOOD PARAMETERS IN TYUMEN RESIDENTS WITH COVID-19 IN CATAMNESIS AND/OR VACCINATED AGAINST A NEW CORONAVIRUS INFECTION. ASSESSMENT OF CHANGES IN HEART RATE VARIABILITY INDICES OF STUDENTS AFTER COVID-19 LOCKDOWN: A COHORT STUDY. CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICLE EJECTION FRACTION (HFPEF) AND RIGHT VENTRICLE INVOLVEMENT IN PATIENTS WITH NORMAL SINUS RHYTHM AND ATRIAL FIBRILLATION; A SMALL OBSERVATIONAL STUDY: RELEVANCE OF THE PROBLEM, DIAGNOSTIC APPROACH, ECHOCARDIOGRAPHIC EVALUATION OF RIGHT VENTRICLE. CLINICAL MANIFESTATION AND EPIDEMIOLOGICAL PECULIARITIES OF LEPTOSPIROSIS AT THE MODERN STAGE IN GEORGIA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1